Class action lawsuits
Investors in Neogen Corporation (NASDAQ: NEOG) may be eligible for compensation in a class action securities lawsuit filed by Levi & Korsinsky, LLP. The lawsuit alleges that the company's management issued materially false and misleading statements regarding the integration with the Food Safety Division of the 3M Company,
Class action lawsuits
Snap investors may be entitled to compensation without paying out-of-pocket fees, with a lead plaintiff deadline set for October 20, 2025. The lawsuit alleges that Snap's optimistic reports about advertising growth and earnings potential fell short of reality, causing investors to suffer damages. Rosen Law Firm, a global
Class action lawsuits
Purchasers of securities of Centene Corporation (NYSE: CNC) between December 12, 2024, and June 30, 2025, may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement. A class action lawsuit has already been filed, and investors are encouraged to select qualified counsel
Class action lawsuits
Alto Neuroscience, Inc. (NYSE: ANRO) faces a class action lawsuit alleging securities fraud, claiming that the company's public statements were materially false and misleading about its product pipeline, ALTO-100, and its clinical, regulatory, and commercial prospects. Investors who purchased or acquired Alto common stock or securities between February
Class action lawsuits
A class action lawsuit has been filed on behalf of Fiserv, Inc. investors who allegedly suffered losses due to the company's alleged securities fraud. The lawsuit alleges that Fiserv made false statements and concealed its financial difficulties, which led to a slowdown in its business growth. The complaint
Class action lawsuits
Fiserv, Inc.'s common stock is being targeted in a class action lawsuit alleging that the company made false and misleading statements during a specific period. The lawsuit claims that Fiserv concealed a slowdown in new merchant business, exaggerated the growth of its Clover platform, and misled investors about
Class action lawsuits
Berger Montague PC, a prominent law firm specializing in securities class action litigation, is investigating claims against Altimmune, Inc. (NASDAQ: ALT) following a class action lawsuit. The lawsuit was filed against the clinical-stage biopharmaceutical company, which focuses on developing therapeutics for obesity and liver disease, including MASH (metabolic dysfunction-associated steatohepatitis)
Class action lawsuits
Alto Neuroscience, a biotech company specializing in innovative treatments for neurological disorders, has been accused of making false and misleading statements to the market regarding the effectiveness of its flagship product, ALTO-100, for the treatment of major depressive disorder (MDD). Shareholders who purchased shares during the company's initial
Class action lawsuits
Alto Neuroscience, a clinical-stage biopharmaceutical company, has been sued in a class action lawsuit over allegedly misleading public statements regarding its product, ALTO-100, which was being tested as a treatment for patients with major depressive disorder. The lawsuit claims that the company's registration statement, prospectus, and other public
Class action lawsuits
Investors who purchased shares of Alto Neuroscience, Inc. during a specific period have been issued a notice to contact The Gross Law Firm regarding possible lead plaintiff appointment in a class action lawsuit. The lawsuit alleges that the company made false and/or misleading statements about its product pipeline, ALTO-100,
Class action lawsuits
Neogen Corporation, a leading company in the animal health and agribusiness sectors, is facing a class action lawsuit alleging violations of federal securities laws. The lawsuit, filed by Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, seeks to recover damages for investors who purchased Neogen securities between January
Class action lawsuits
The Gross Law Firm has issued a notice to shareholders of Snap Inc. (NYSE: SNAP) regarding possible lead plaintiff appointment in a class action lawsuit. Shareholders who purchased shares of SNAP during the class period of April 29, 2025, to August 5, 2025, are encouraged to contact the firm. The
